4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Nemiralisib: new trials by email Literature Review of Nemiralisib trials Research Report on Nemiralisib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib Nemiralisib, Itraconazole - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | GlaxoSmithKline | 20 | 2018-01-17 | 2020-04-27 |
| Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects GSK2269557 500 µg, GSK2269557 750 µg - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | GlaxoSmithKline | 12 | 2017-06-15 | 2019-08-19 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects GSK2269557, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | GlaxoSmithKline | 45 | 2013-01-09 | 2017-07-13 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557 GSK2269557, GSK2269557 matching placebo - Asthma | Phase 1 | Completed | GlaxoSmithKline | 61 | 2011-07-24 | 2017-07-25 |
Pulmonary Disease, Chronic Obstructive (3) · Asthma (1) · Respiratory Aspiration (1)
GlaxoSmithKline (4)
United Kingdom (3) · United States (1)
2017 (1)